Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Medtronic plc stock logo
MDT
Medtronic
$89.25
-1.4%
$89.58
$69.32
$92.68
$114.45B0.846.21 million shs6.96 million shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Medtronic plc stock logo
MDT
Medtronic
+0.25%-1.86%+0.58%+12.50%+28.33%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Medtronic plc stock logo
MDT
Medtronic
4.6837 of 5 stars
2.23.03.34.02.61.72.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Medtronic plc stock logo
MDT
Medtronic
2.44
Hold$95.366.85% Upside

Current Analyst Ratings

Latest MDT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/25/2024
Medtronic plc stock logo
MDT
Medtronic
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
10/14/2024
Medtronic plc stock logo
MDT
Medtronic
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$90.00 ➝ $93.00
10/10/2024
Medtronic plc stock logo
MDT
Medtronic
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Perform ➝ Outperform$98.00 ➝ $105.00
10/8/2024
Medtronic plc stock logo
MDT
Medtronic
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$92.00 ➝ $98.00
10/1/2024
Medtronic plc stock logo
MDT
Medtronic
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$85.00 ➝ $92.00
10/1/2024
Medtronic plc stock logo
MDT
Medtronic
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$100.00 ➝ $104.00
8/23/2024
Medtronic plc stock logo
MDT
Medtronic
Daiwa America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
8/23/2024
Medtronic plc stock logo
MDT
Medtronic
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$85.00 ➝ $90.00
8/22/2024
Medtronic plc stock logo
MDT
Medtronic
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$104.00 ➝ $105.00
8/21/2024
Medtronic plc stock logo
MDT
Medtronic
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$85.00 ➝ $90.00
(Data available from 10/31/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Medtronic plc stock logo
MDT
Medtronic
$32.58B3.51$7.05 per share12.65$37.97 per share2.35

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Medtronic plc stock logo
MDT
Medtronic
$3.68B$2.9630.1515.312.6012.06%13.68%7.67%11/19/2024 (Estimated)

Latest MDT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/20/2024Q1 2025
Medtronic plc stock logo
MDT
Medtronic
$1.20$1.23+$0.03$1.66$7.90 billion$7.97 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Medtronic plc stock logo
MDT
Medtronic
$2.803.14%+6.45%94.59%48 Years

Latest MDT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/15/2024
Medtronic plc stock logo
MDT
Medtronic
Quarterly$0.703.31%9/27/20249/27/202410/11/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Medtronic plc stock logo
MDT
Medtronic
0.55
2.13
1.61

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Medtronic plc stock logo
MDT
Medtronic
82.06%

Insider Ownership

CompanyInsider Ownership
Medtronic plc stock logo
MDT
Medtronic
0.20%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Medtronic plc stock logo
MDT
Medtronic
95,0001.28 billion1.28 billionOptionable

MDT Headlines

Recent News About These Companies

Medtronic plc stock logo
Medtronic plc (NYSE:MDT) Shares Sold by US Bancorp DE
(MDT) Proactive Strategies
Medtronic's Q2 2025 Earnings: What to Expect
Medtronic plc stock logo
abrdn plc Reduces Stock Holdings in Medtronic plc (NYSE:MDT)
Needham & Company LLC Reaffirms "Hold" Rating for Medtronic (NYSE:MDT)
Medtronic wins CE mark for Evolut FX+
Medtronic’s Affera PFA snags FDA approval

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Medtronic logo

Medtronic

NYSE:MDT
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.